Correction: Treatment trends and risks of corticosteroid use in adult primary immune thrombocytopenia: a claims database study in Japan
Hirokazu Kashiwagi, Isao Miura, Naohiko Terasawa, Ken-ichi Iwayama, Yuka Furukawa, Makoto Kanenishi
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPlatelet Disorders and Treatments · Myeloproliferative Neoplasms: Diagnosis and Treatment · Cell Adhesion Molecules Research
Correction: International Journal of Hematology 10.1007/s12185-024-03897-8
The article ‘Treatment trends and risks of corticosteroid use in adult primary immune thrombocytopenia: a claims database study in Japan’, written by Hirokazu Kashiwagi, Isao Miura, Naohiko Terasawa, Ken‑ichi Iwayama, Yuka Furukawa, Makoto Kanenishi, was originally published under exclusive license to Japanese Society of Hematology. As a result of the subsequent decision to publish the article under the open access model, the article’s copyright notice was changed on 30 December 2024 to © The Author(s) 2025 and the article is now distributed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The original article has been corrected.